Ryzodeg to be launched April 24

Novo Nordisk, world's largest insulin maker is going to launch Ryzodeg for people with type 2 diabetes in Bangladesh on April 24, 2015.
Ryzodeg provides successful glycaemic control, fewer injections and lower rates of hypoglycaemia compared to basal-bolus insulins, Sanjay Kalra, consultant endocrinologist, Bharti Hospital, India said Saturday.
"People with diabetes currently using basal-bolus regimens may need to take up to four daily injections, which can be inconvenient and stressful. Ryzodeg requires only two injections daily," Kalra said.
He spoke at the country's first "International Diabetes Conference 2015" at Mymensingh Medical College (MMC), according to a statement.
The conference was organised by MMC in association with Novo Nordisk Pharma (Pvt.) Ltd., the global leader in diabetic care. Prominent endocrinologists and diabetologists from abroad have participated at the conferences.
"Ryzodeg is an innovative product that will give the health care professional a better way to manage the condition," he said.